Evidence map›Paper›PMID 35320302›Full record

ArticlePloS one2022

Perspectives of individuals with sickle cell disease on barriers to care.

Shannon Phillips, Yumei Chen, Rita Masese, Laurence Noisette, Kasey Jordan, Sara Jacobs, Lewis L Hsu, Cathy L Melvin, Marsha Treadwell, Nirmish Shah and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Barriers to Care for Adults With Sickle Cell Disease: A Qualitative Descriptive Study.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Shannon PhillipsCollege of Nursing, Medical University of South Carolina, Charleston, SC, United States of America.ORCID 0000-0001-5697-9156
Yumei ChenDepartment of Hematology/Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America.
Rita MaseseSchool of Nursing, Duke University, Durham, NC, United States of America.
Laurence NoisetteDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States of America.ORCID 0000-0001-6138-7753
Kasey JordanCollege of Nursing, Medical University of South Carolina, Charleston, SC, United States of America.
Sara JacobsTranslational Health Research Division, RTI International, Research Triangle Park, NC, United States of America.
Lewis L HsuDepartment of Pediatrics, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, United States of America.
Cathy L MelvinDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States of America.
Marsha TreadwellDepartment of Pediatrics/Division of Hematology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America.
Nirmish ShahSchool of Medicine, Duke University, Durham, NC, United States of America.ORCID 0000-0002-7506-0935
Paula TanabeSchool of Nursing, Duke University, Durham, NC, United States of America.
Julie KanterDivision of Hematology & Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America.ORCID 0000-0001-7002-8891
Medical University of South Carolina · USDuke University · USUCSF Benioff Children's Hospital · USRTI International · USUniversity of Alabama at Birmingham · USUniversity of Illinois Chicago · US

Funding

Data Coordinating Center for Sickle Cell Disease Implementation Consortium (SCDIC)U24HL133948 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI JACOBS, SARA RUBIN, KRONER, BARBARA L · 2016 to 2021
$7.3M
New York City Sickle Cell Implementation Science ConsortiumU01HL133997 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RICHARDSON, LYNNE D. · 2016 to 2021
$5.4M
The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and BackU01HL133994 · NHLBI · WASHINGTON UNIVERSITY · PI KING, ALLISON A · 2016 to 2021
$5.2M
Improving Sickle cell care in Adolescents & Adults in Chicago (ISAAC)U01HL134042 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GORDEUK, VICTOR R, HIRSCHTICK, JANA · 2016 to 2021
$5.1M
Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell DiseaseU01HL134004 · NHLBI · AUGUSTA UNIVERSITY · PI GIBSON, ROBERT WILLIAM, KUTLAR, ABDULLAH · 2016 to 2021
$5.0M
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North CarolinaU01HL133964 · NHLBI · DUKE UNIVERSITY · PI SHAH, NIRMISH R, TANABE, PAULA · 2016 to 2021
$4.8M
RE-aiming at Hydroxyurea Adherence for Sickle cell with mHealth (RE-HASH)U01HL133996 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HANKINS, JANE SILVA, KLESGES, LISA M · 2016 to 2021
$4.6M
SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease CareU01HL134007 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TREADWELL, MARSHA J, VICHINSKY, ELLIOTT P · 2016 to 2021
$4.1M
Implementation of a Sickle Cell Enhanced Novel Care Network in South Carolina (iSCENSC)U01HL133990 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FLOREZ, HERMES JOSE · 2016 to 2021
$4.1M
SMYLS: A Self-Management Program for Youth Living with Sickle Cell DiseaseK23NR017899 · NINR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PHILLIPS, SHANNON M. · 2019 to 2021
$426k
NHLBI NIH HHS U01 HL133964NHLBI NIH HHS U01 HL133990NHLBI NIH HHS U01 HL133994NHLBI NIH HHS U01 HL133996NHLBI NIH HHS U01 HL133997NHLBI NIH HHS U01 HL134004NHLBI NIH HHS U01 HL134007NHLBI NIH HHS U01 HL134042NHLBI NIH HHS U24 HL133948NINR NIH HHS K23 NR017899
6 · The paper itself

Abstract

introductionSickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with complications leading to high healthcare utilization rates, including emergency department (ED) visits and hospitalizations. Optimal SCD care requires a multidisciplinary approach involving SCD specialists to ensure preventive care, minimize complications and prevent unnecessary ED visits and hospitalizations. However, most individuals with SCD receive sub-optimal care or are unaffiliated with care (have not seen an SCD specialist). We aimed to identify barriers to care from the perspective of individuals with SCD in a multi-state sample.

methodsWe performed a multiple methods study consisting of surveys and interviews in three comprehensive SCD centers from March to June 2018. Interviews were transcribed and coded, exploring themes around barriers to care. Survey questions on the specific themes identified in the interviews were analyzed using summary statistics.

resultsWe administered surveys to 208 individuals and conducted 44 in-depth interviews. Barriers to care were identified and classified according to ecological level (i.e., individual, family/interpersonal, provider, and socio-environmental/organizational level). Individual-level barriers included lack of knowledge in self-management and disease severity. Family/interpersonal level barriers were inadequate caregiver support and competing life demands. Provider level barriers were limited provider knowledge, provider inexperience, poor provider-patient relationship, being treated differently, and the provider's lack of appreciation of the patient's SCD knowledge. Socio-environmental/organizational level barriers included limited transportation, lack of insurance, administrative barriers, poor care coordination, and reduced access to care due to limited clinic availability, services provided or clinic refusal to provide SCD care.

conclusionParticipants reported several multilevel barriers to SCD care. Strategies tailored towards reducing these barriers are warranted. Our findings may also inform interventions aiming to locate and link unaffiliated individuals to care.

Indexed as

Anemia, Sickle CellEmergency Service, HospitalHealth ServicesHealth Services AccessibilityHospitalizationHumansUnited States

Identifiers

PMID35320302
PMCPMC8942270
OpenAlexW4220921533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.